JP2005522452A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005522452A5 JP2005522452A5 JP2003567882A JP2003567882A JP2005522452A5 JP 2005522452 A5 JP2005522452 A5 JP 2005522452A5 JP 2003567882 A JP2003567882 A JP 2003567882A JP 2003567882 A JP2003567882 A JP 2003567882A JP 2005522452 A5 JP2005522452 A5 JP 2005522452A5
- Authority
- JP
- Japan
- Prior art keywords
- benzo
- tetrahydro
- azepine
- alkyl
- phenylsulfonamido
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0203437A GB0203437D0 (en) | 2002-02-13 | 2002-02-13 | Novel compounds |
| GB0204758A GB0204758D0 (en) | 2002-02-28 | 2002-02-28 | Novel compounds |
| GB0212548A GB0212548D0 (en) | 2002-05-30 | 2002-05-30 | Novel compounds |
| GB0219711A GB0219711D0 (en) | 2002-08-23 | 2002-08-23 | Novel compounds |
| PCT/EP2003/001543 WO2003068751A1 (en) | 2002-02-13 | 2003-02-13 | 7-arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo'diazepine derivatives with 5-ht6 receptor affinity for the reatment of cns disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005522452A JP2005522452A (ja) | 2005-07-28 |
| JP2005522452A5 true JP2005522452A5 (enExample) | 2006-01-05 |
Family
ID=27739230
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003567882A Pending JP2005522452A (ja) | 2002-02-13 | 2003-02-13 | Ｃｎｓ疾患の治療のための、５−ｈｔ６受容体アフィニティーを有する７−アリールスルホンアミド−２，３，４，５−テトラヒドロ−１ｈ−ベンゾ’ジアゼピン誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20050090485A1 (enExample) |
| EP (1) | EP1487801B1 (enExample) |
| JP (1) | JP2005522452A (enExample) |
| AR (1) | AR038421A1 (enExample) |
| AT (1) | ATE323680T1 (enExample) |
| AU (1) | AU2003206909A1 (enExample) |
| DE (1) | DE60304695T2 (enExample) |
| ES (1) | ES2260607T3 (enExample) |
| TW (1) | TW200306843A (enExample) |
| WO (1) | WO2003068751A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005526724A (ja) * | 2002-02-13 | 2005-09-08 | グラクソ グループ リミテッド | 抗精神病剤としてのベンゼンスルホンアミド誘導体 |
| JP2005517705A (ja) * | 2002-02-13 | 2005-06-16 | グラクソ グループ リミテッド | ベンゼンスルホンアミド誘導体ならびにドーパミンｄ３およびｄ２受容体リガンドとしてのその使用 |
| MXPA04009318A (es) * | 2002-03-27 | 2005-01-25 | Glaxo Group Ltd | Derivados de quinolina y su uso como ligados 5-ht6. |
| TWI281914B (en) | 2002-05-29 | 2007-06-01 | Glaxo Group Ltd | Compounds |
| JP4198733B2 (ja) | 2003-07-22 | 2008-12-17 | アリーナ ファーマシューティカルズ， インコーポレイテッド | 関連性障害の予防および処置に有用な、５−ｈｔ２ａセロトニンレセプターのモジュレーターとしてのジアリールおよびアリールへテロアリールウレア誘導体 |
| GB0329214D0 (en) * | 2003-12-17 | 2004-01-21 | Glaxo Group Ltd | Novel compounds |
| MXPA06006858A (es) * | 2003-12-18 | 2006-09-04 | Abbott Gmbh & Co Kg | Tetrahidrobenzacepinas y su uso en la modulacion del receptor d3 de la dopamina. |
| US20050137186A1 (en) * | 2003-12-18 | 2005-06-23 | Abbott Gmbh & Co. Kg. | Tetrahydrobenzazepines and their use |
| EP1756094A1 (en) * | 2004-06-18 | 2007-02-28 | Glaxo Group Limited | 3-cycloalkylbenzazepines as histamine h3 antagonists |
| EP1809619A1 (en) * | 2004-10-21 | 2007-07-25 | Transtech Pharma, Inc. | Bissulfonamide compounds as agonists of galr1, compositions, and methods of use |
| US20100173890A1 (en) * | 2005-07-05 | 2010-07-08 | Astrazeneca Ab | Compounds, Process for their Preparation, Intermediates, Pharmaceutical Compositions and their use in the Treatment of 5-HT6 Mediated Disorders such as Alzheimer's Disease, Cognitive Disorders, Cognitive Impairment Associated with Schizophrenia, Obesity and Parkinson's Disease |
| JP2009501705A (ja) * | 2005-07-05 | 2009-01-22 | アストラゼネカ・アクチエボラーグ | 新規化合物、その製造方法、中間体、医薬組成物、並びにアルツハイマー病、認知障害、統合失調症に伴う認識機能障害、肥満及びパーキンソン病のような５−ｈｔ６介在疾患の治療におけるそれらの使用 |
| WO2008113818A1 (en) * | 2007-03-21 | 2008-09-25 | Glaxo Group Limited | Use of quinoline derivatives in the treatment of pain and irritable bowel syndrome |
| EP2508177A1 (en) | 2007-12-12 | 2012-10-10 | Glaxo Group Limited | Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline |
| US20110021538A1 (en) | 2008-04-02 | 2011-01-27 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
| US9126946B2 (en) | 2008-10-28 | 2015-09-08 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto |
| CN103145619A (zh) * | 2012-06-15 | 2013-06-12 | 史慎德 | 7-氯-6-苯磺酰氨基-2,3,4,5-四氢-1H-苯并[d]氮杂*的制备 |
| WO2016201373A1 (en) | 2015-06-12 | 2016-12-15 | Axovant Sciences Ltd. | Diaryl and arylheteroaryl urea derivatives useful for the prophylaxis and treatment of rem sleep behavior disorder |
| HK1247555A1 (zh) | 2015-07-15 | 2018-09-28 | Axovant Sciences Gmbh | 用於预防和治疗与神经变性疾病相关的幻觉的作为5-ht2a血清素受体的调节剂的二芳基脲和芳基杂芳基脲衍生物 |
| BR112018013955B1 (pt) * | 2016-01-15 | 2024-01-16 | Pfizer Inc | Compostos ligantes de dopamina d3 de 6,7,8,9-tetra-hidro-5h-pirido [2,3- d] azepina, composição farmacêutica que os compreende e uso dos mesmos |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3314963A (en) * | 1962-07-23 | 1967-04-18 | Pfizer & Co C | Azabenzocycloalkane-n-carboxamidines |
| DE3614863A1 (de) * | 1986-05-02 | 1987-11-05 | Wabco Westinghouse Fahrzeug | Betaetigungseinrichtung fuer eine differentialsperre mit einem stellglied |
| US5006521A (en) * | 1988-06-01 | 1991-04-09 | Smithkline Beecham Corporation | α-adrenergic receptor antagonists and methods of use thereas |
| US4978660A (en) * | 1988-06-01 | 1990-12-18 | Smithkline Beecham Corporation | α-adrenergic receptor antagonists |
| US4959360A (en) * | 1988-06-01 | 1990-09-25 | Smithkline Beecham Corporation | α-adrenergic receptor antagonists |
| US5939451A (en) * | 1996-06-28 | 1999-08-17 | Hoffmann-La Roche Inc. | Use of sulfonamides |
| DZ2376A1 (fr) * | 1996-12-19 | 2002-12-28 | Smithkline Beecham Plc | Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant. |
| EP0994862B1 (en) * | 1997-07-11 | 2005-06-01 | SmithKline Beecham plc | Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation |
| GB9801392D0 (en) * | 1998-01-22 | 1998-03-18 | Smithkline Beecham Plc | Novel compounds |
| GB9803411D0 (en) * | 1998-02-18 | 1998-04-15 | Smithkline Beecham Plc | Novel compounds |
| GB9926302D0 (en) * | 1999-11-05 | 2000-01-12 | Smithkline Beecham Plc | Novel compounds |
| GB0111186D0 (en) * | 2001-05-08 | 2001-06-27 | Smithkline Beecham Plc | Novel compounds |
| JP2005517705A (ja) * | 2002-02-13 | 2005-06-16 | グラクソ グループ リミテッド | ベンゼンスルホンアミド誘導体ならびにドーパミンｄ３およびｄ２受容体リガンドとしてのその使用 |
| JP2005526724A (ja) * | 2002-02-13 | 2005-09-08 | グラクソ グループ リミテッド | 抗精神病剤としてのベンゼンスルホンアミド誘導体 |
-
2003
- 2003-02-13 ES ES03704631T patent/ES2260607T3/es not_active Expired - Lifetime
- 2003-02-13 US US10/503,678 patent/US20050090485A1/en not_active Abandoned
- 2003-02-13 TW TW092102942A patent/TW200306843A/zh unknown
- 2003-02-13 AU AU2003206909A patent/AU2003206909A1/en not_active Abandoned
- 2003-02-13 WO PCT/EP2003/001543 patent/WO2003068751A1/en not_active Ceased
- 2003-02-13 AT AT03704631T patent/ATE323680T1/de not_active IP Right Cessation
- 2003-02-13 EP EP03704631A patent/EP1487801B1/en not_active Expired - Lifetime
- 2003-02-13 JP JP2003567882A patent/JP2005522452A/ja active Pending
- 2003-02-13 AR ARP030100475A patent/AR038421A1/es unknown
- 2003-02-13 DE DE60304695T patent/DE60304695T2/de not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005522452A5 (enExample) | ||
| JP2005518414A5 (enExample) | ||
| US11434207B2 (en) | P2X4 receptor antagonist | |
| JP2006505623A5 (enExample) | ||
| CN103038231B (zh) | Hec1活性调节剂及其方法 | |
| CN110621664B (zh) | 新型哌啶-2,6-二酮衍生物及其用途 | |
| JP2005527542A5 (enExample) | ||
| RU2004131641A (ru) | Новые соединения | |
| RU2005130514A (ru) | 2,5- и 2,6-замещенные тетрагидроизохинолины, предназначенные для применения в качестве модуляторов 5-нт6 | |
| CN103237794B (zh) | P2x4受体拮抗剂 | |
| JP2004534755A5 (enExample) | ||
| JP2009513703A5 (enExample) | ||
| CN107531683B (zh) | Usp7抑制剂化合物及使用方法 | |
| CN105218532B (zh) | 苯并三氮唑类化合物、制备方法和其医药用途 | |
| JP2009537542A5 (enExample) | ||
| KR20030011093A (ko) | 비스-아릴술폰 | |
| AR038421A1 (es) | Compuesto sulfonamida de 1,2,4,5-tetrahidrobenzo (d) azepina, procedimiento para su preparacion, composicion farmaceutica que lo comprende y su uso para preparar esta ultima | |
| JP2008506695A5 (enExample) | ||
| RU2005111590A (ru) | 2,4-замещенные индолы и их использование в качестве модуляторов 5-гт6 | |
| JP2008509222A5 (enExample) | ||
| CN102131791A (zh) | 二苯并硫杂氮杂*衍生物及其用途 | |
| RU2005138147A (ru) | Применение сульфонамидных производных для изготовления лекарственного средства, предназначенного для профилактики и/или лечения нарушений потребления пищи | |
| WO2018208123A1 (ko) | 신규한 피페리딘-2,6-디온 유도체 및 이의 용도 | |
| JP2006504794A5 (enExample) | ||
| JP2005531580A5 (enExample) |